Literature DB >> 34137233

Research progress on transient receptor potential melastatin 2 channel in nervous system diseases.

Yingchao Ying1, Peifang Jiang1.   

Abstract

Transient receptor potential M2 (TRPM2) ion channel is a non-selective cationic channel that can permeate calcium ions, and plays an important role in neuroinflammation, ischemic reperfusion brain injury, neurodegenerative disease, neuropathic pain, epilepsy and other neurological diseases. In ischemic reperfusion brain injury, TRPM2 mediates neuronal death by modulating the different subunits of glutamate N-methyl-D-aspartic acid receptor in response to calcium/zinc signal. In Alzheimer's disease, TRPM2 is activated by reactive oxygen species generated by β-amyloid peptide to form a malignant positive feedback loop that induces neuronal death and is involved in the pathological process of glial cells by promoting inflammatory response and oxidative stress. In epilepsy, the TRPM2-knockout alleviates epilepsy induced neuronal degeneration by inhibiting autophagy and apoptosis related proteins. The roles of TRPM2 channel in the pathogenesis of various central nervous system diseases and its potential drug development and clinical application prospects are summarized in this review.

Entities:  

Keywords:  Alzheimer’s disease; Epilepsy; Ischemia-reperfusion brain injury; Juvenile myoclonic epilepsy; Nervous system diseases; Review; Transient receptor potential melastain 2

Mesh:

Substances:

Year:  2021        PMID: 34137233      PMCID: PMC8710270          DOI: 10.3724/zdxbyxb-2021-0110

Source DB:  PubMed          Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban        ISSN: 1008-9292


  67 in total

Review 1.  Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease.

Authors:  Frank M LaFerla
Journal:  Nat Rev Neurosci       Date:  2002-11       Impact factor: 34.870

2.  Transient receptor potential melastatin 2 contributes to neuroinflammation and negatively regulates cognitive outcomes in a pilocarpine-induced mouse model of epilepsy.

Authors:  Hui Hu; Tao Zhu; Lifen Gong; Yisha Zhao; Yu Shao; Shufen Li; Zengxian Sun; Yinjie Ling; Yilin Tao; Yingchao Ying; Chenfu Lan; Yicheng Xie; Peifang Jiang
Journal:  Int Immunopharmacol       Date:  2020-07-27       Impact factor: 4.932

3.  A critical role of TRPM2 in neuronal cell death by hydrogen peroxide.

Authors:  Shuji Kaneko; Seiko Kawakami; Yuji Hara; Minoru Wakamori; Etsuko Itoh; Toshiyuki Minami; Yuki Takada; Toshiaki Kume; Hiroshi Katsuki; Yasuo Mori; Akinori Akaike
Journal:  J Pharmacol Sci       Date:  2006-04-29       Impact factor: 3.337

4.  CACNA1H variants are not a cause of monogenic epilepsy.

Authors:  Jeffrey D Calhoun; Alexandra M Huffman; Irena Bellinski; Lisa Kinsley; Elizabeth Bachman; Elizabeth Gerard; Jennifer A Kearney; Gemma L Carvill
Journal:  Hum Mutat       Date:  2020-04-14       Impact factor: 4.878

5.  TRPM2 Promotes Neurotoxin MPP+/MPTP-Induced Cell Death.

Authors:  Yuyang Sun; Pramod Sukumaran; Senthil Selvaraj; Nicholas I Cilz; Anne Schaar; Saobo Lei; Brij B Singh
Journal:  Mol Neurobiol       Date:  2016-12-12       Impact factor: 5.590

6.  Effects of homocysteine and memantine on oxidative stress related TRP cation channels in in-vitro model of Alzheimer's disease.

Authors:  İshak Suat Övey; Mustafa Nazıroğlu
Journal:  J Recept Signal Transduct Res       Date:  2020-08-11       Impact factor: 2.092

7.  CACNA1H Mutations Are Associated With Different Forms of Primary Aldosteronism.

Authors:  Georgios Daniil; Fabio L Fernandes-Rosa; Jean Chemin; Iulia Blesneac; Jacques Beltrand; Michel Polak; Xavier Jeunemaitre; Sheerazed Boulkroun; Laurence Amar; Tim M Strom; Philippe Lory; Maria-Christina Zennaro
Journal:  EBioMedicine       Date:  2016-10-04       Impact factor: 8.143

Review 8.  TRPM2: a candidate therapeutic target for treating neurological diseases.

Authors:  Jillian Corinne Belrose; Michael Frederick Jackson
Journal:  Acta Pharmacol Sin       Date:  2018-04-19       Impact factor: 6.150

9.  One Single Nucleotide Polymorphism of the TRPM2 Channel Gene Identified as a Risk Factor in Bipolar Disorder Associates with Autism Spectrum Disorder in a Japanese Population.

Authors:  Naila Al Mahmuda; Shigeru Yokoyama; Toshio Munesue; Kenshi Hayashi; Kunimasa Yagi; Chiharu Tsuji; Haruhiro Higashida
Journal:  Diseases       Date:  2020-02-07

Review 10.  TRPM2 channel: A novel target for alleviating ischaemia-reperfusion, chronic cerebral hypo-perfusion and neonatal hypoxic-ischaemic brain damage.

Authors:  Chendi Mai; Harneet Mankoo; Linyu Wei; Xinfang An; Chaokun Li; Dongliang Li; Lin-Hua Jiang
Journal:  J Cell Mol Med       Date:  2019-09-30       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.